A notable advancement in glucose treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and https://matteoerrl056180.illawiki.com/2347217/significant_introduction_tirzepatide_strength_for_glucose_management